 |
인쇄하기
취소
|
Estech signs drug export deal
Local active pharmaceutical ingredient (API) maker Estech Pharma signed a contract with India's largest pharmaceutical company on November 10 to export Planlukast, an antiarthmatic medicine.
The deal with Ranbaxy Laboratories Ltd. is in the scale of $7.3 million for five years.
The deal allows Ranbaxy to have exclusive sales rights of Planlukast in Japan, once it succeeds in obtaining Ja...
The deal with Ranbaxy Laboratories Ltd. is in the scale of $7.3 million for five years.
The deal allows Ranbaxy to have exclusive sales rights of Planlukast in Japan, once it succeeds in obtaining Ja...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.